Pancreatic Cancer Stromal Reprogramming Consortium
@nci-psrc.bsky.social
We are a NCI funded consortium that is focused on understanding how to reprogram the stroma in pancreatic ductal adenocarcinoma (PDAC) in order to improve treatment responses and enhance survival. The coordinating center for PSRC is based at MD Anderson.
Tremendous resource paper from NCI-PSRC member Nina Steele on collating a single cell RNA SEQ dataset in #PancreaticCancer
The dataset is now housed with the PSRC.
aacrjournals.org/clincancerre...
The dataset is now housed with the PSRC.
aacrjournals.org/clincancerre...
December 10, 2024 at 1:38 PM
Tremendous resource paper from NCI-PSRC member Nina Steele on collating a single cell RNA SEQ dataset in #PancreaticCancer
The dataset is now housed with the PSRC.
aacrjournals.org/clincancerre...
The dataset is now housed with the PSRC.
aacrjournals.org/clincancerre...
The semi annual virtual meeting of the NCI PSRC is happening now. Here NCI highlights the top ten papers from the consortium thus far.
December 3, 2024 at 4:22 PM
The semi annual virtual meeting of the NCI PSRC is happening now. Here NCI highlights the top ten papers from the consortium thus far.
The incidence of #PancreaticCancer in women with a BRCA1 or BRCA2 mutation
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
The cumulative incidence from age 40 to 80 years was 2.2% for BRCA1 carriers and 2.7% for BRCA2 carriers. Most did not have a family history of the disease.
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
The cumulative incidence from age 40 to 80 years was 2.2% for BRCA1 carriers and 2.7% for BRCA2 carriers. Most did not have a family history of the disease.
November 29, 2024 at 2:00 PM
The incidence of #PancreaticCancer in women with a BRCA1 or BRCA2 mutation
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
The cumulative incidence from age 40 to 80 years was 2.2% for BRCA1 carriers and 2.7% for BRCA2 carriers. Most did not have a family history of the disease.
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
The cumulative incidence from age 40 to 80 years was 2.2% for BRCA1 carriers and 2.7% for BRCA2 carriers. Most did not have a family history of the disease.